AnGes Inc (4563):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:AnGes Inc (4563) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7488
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AnGes Inc (AnGes) is a biopharmaceutical company which discovers and develops gene and nucleotide based drugs and reagents for use in functional analysis of genetic medication. The company specializes in research and development (R&D) and practical application of genetic medicine. It has two projects under development, namely, a hepatocyte growth factor (HGF) plasmid, a genetic medicine that regenerates blood vessels improving blood circulation and NF-KB decoy oligonuvleotide. It also develops therapeutic vaccine projects including, Allovectin, a cancer treatment drug; and DNA and CIN (cervical intraepithelial neoplasia) therapeutic vaccines. AnGes is headquartered in Osaka, Japan.

AnGes Inc (4563) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AnGes Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AnGes Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
AnGes Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AnGes Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
AnGes Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
AnGes Inc, Medical Equipment, Deal Details 10
Partnerships 10
AnGes MG Enters into Agreement with Morishita Jintan 10
AnGes MG Enters Into Co-Development Agreement With Medikit For Drug-Coated PTA Balloon Catheter 11
Equity Offering 12
AnGes MG Raises USD2.6 Million in Private Placement of Shares upon Exercise of Warrants 12
AnGes Inc – Key Competitors 13
AnGes Inc – Key Employees 14
AnGes Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
AnGes Inc, Medical Equipment, Key Facts, 2017 2
AnGes Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
AnGes Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AnGes Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
AnGes Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AnGes Inc, Deals By Market, 2012 to YTD 2018 8
AnGes Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
AnGes MG Enters into Agreement with Morishita Jintan 10
AnGes MG Enters Into Co-Development Agreement With Medikit For Drug-Coated PTA Balloon Catheter 11
AnGes MG Raises USD2.6 Million in Private Placement of Shares upon Exercise of Warrants 12
AnGes Inc, Key Competitors 13
AnGes Inc, Key Employees 14
AnGes Inc, Other Locations 15
AnGes Inc, Subsidiaries 15

List of Figures
AnGes Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
AnGes Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
AnGes Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
AnGes Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
AnGes Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AnGes Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
AnGes Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AnGes Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[AnGes Inc (4563):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PACCAR Inc (PCAR):企業の財務・戦略的SWOT分析
    PACCAR Inc (PCAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • BioMotiv LLC-製薬・医療分野:企業M&A・提携分析
    Summary BioMotiv LLC (BioMotiv) is a development company specializes in the licensing and development of therapeutics across wide disease areas including proteins, small molecules, antibodies, and nucleotides. The company in association with The Harrington Project for Discovery & Development acceler …
  • Teleflex Inc (TFX):企業の財務・戦略的SWOT分析
    Teleflex Inc (TFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • HTC Corporation:企業の戦略・SWOT・財務情報
    HTC Corporation - Strategy, SWOT and Corporate Finance Report Summary HTC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Dirui Industrial Co Ltd (300396):企業の財務・戦略的SWOT分析
    Summary Dirui Industrial Co Ltd (Dirui) is a provider of total laboratory solutions. The company designs, develops, manufactures, and markets diagnostic medical equipment, reagents, and clinical diagnostic reagents. Its products include chemistry analyzer, urine analyzer, hematology analyzer, fecal …
  • Neuravi Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Neuravi Ltd (Neuravi) is a medical device company that develops and commercializes endovascular devices and stroke treatment. The company provides embotrap revascularization device which is a thrombectomy system designed with clot-device mechanics to address challenging occlusions. Its embot …
  • The Greenbrier Companies, Inc.:企業の戦略・SWOT・財務分析
    The Greenbrier Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Greenbrier Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Rakuten, Inc. (4755):企業の財務・戦略的SWOT分析
    Rakuten, Inc. (4755) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • The Medicines Company (MDCO)-医療機器分野:企業M&A・提携分析
    Summary The Medicines Company (TMC) is a biopharmaceutical company, which provides medical solutions for improving health conditions in patients under critical care. The company’s product portfolio comprises marketed products, namely, Angiomax (bivalirudin), Orbactiv (oritavancin), Minocin (minocycl …
  • Exxon Mobil Corp (XOM):電力:M&Aディール及び事業提携情報
    Summary Exxon Mobil Corp (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. It is a major manufacturer and …
  • Baker Hughes Incorporated (BHGE)-石油・ガス分野:企業M&A・提携分析
    Summary Baker Hughes Incorporated (Baker Hughes), a subsidiary of General Electric Co is a provider of oil and gas equipment and services. The company is a supplier of oilfield services, products, technology and systems to oil and gas industry. It also offers industrial and other products and servic …
  • MaaT Pharma:製薬・医療:M&Aディール及び事業提携情報
    Summary MaaT Pharma (MaaT) is a biotechchnology company that develop novel treatments for Gut Microbiota - dysbiosis related diseases. The company focuses on developing MaaT001, an innovative live frozen inoculum suspension and MaaT002, an innovative device for stool collection and storage. It also …
  • Securitas AB (SECU B):企業の財務・戦略的SWOT分析
    Securitas AB (SECU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Travelsky Technology Ltd (696):企業の財務・戦略的SWOT分析
    Travelsky Technology Ltd (696) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Petro-Victory Energy Corp (VRY):石油・ガス:M&Aディール及び事業提携情報
    Summary Petro-Victory Energy Corp (Petro-Victory) is an oil and gas company that provides exploration and production of hydrocarbon, oil and natural gas resources. The company provides onshore exploration to identify prospective resources, promote and initiate drilling campaigns to find hydrocarbon …
  • Cocrystal Pharma Inc (COCP):企業の財務・戦略的SWOT分析
    Summary Cocrystal Pharma Inc (Cocrystal Pharma), formerly Biozone Pharmaceuticals Inc, a subsidiary of MusclePharm Corp, is a clinical stage biotechnology company that discovers and develops novel antiviral therapeutics. The company provides treatments for chronic viral diseases. Its pipeline produc …
  • CIT Group Inc:企業のM&A・事業提携・投資動向
    CIT Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CIT Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Astellas Pharma Inc.:企業の戦略・SWOT・財務分析
    Astellas Pharma Inc. - Strategy, SWOT and Corporate Finance Report Summary Astellas Pharma Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Emerson Radio Corporation (MSN):企業の財務・戦略的SWOT分析
    Emerson Radio Corporation (MSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Silence Therapeutics Plc (SLN):企業の財務・戦略的SWOT分析
    Summary Silence Therapeutics plc (Silence Therapeutics), formerly SR Pharma plc is a developer of therapeutics that channels gene silencing to cure disease. The company develops pipeline products such as Atu027 and Atu111. Its Atu027 is developed for the treatment of pancreatic, head and neck cancer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆